The present invention provides formulations of anti-LAG3 antibodies, and co-formulations of anti-PD-1 antibodies and anti-LAG3 antibodies, and their use in treating various disorders.La présente invention concerne des formulations d'anticorps anti-LAG3, et des co-formulations d'anticorps anti-PD-1 et d'anticorps anti-LAG3, et leur utilisation dans le traitement de divers troubles.